BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 84 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $75,611 | -64.3% | 11,353 | 0.0% | 0.00% | – |
| Q1 2023 | $211,847 | -17.4% | 11,353 | -4.9% | 0.00% | – |
| Q4 2022 | $256,364 | -6.8% | 11,935 | -48.8% | 0.00% | -100.0% |
| Q3 2022 | $275,000 | +4.2% | 23,307 | +16.7% | 0.00% | – |
| Q2 2022 | $264,000 | -34.5% | 19,974 | +3.6% | 0.00% | -100.0% |
| Q1 2022 | $403,000 | -56.2% | 19,280 | -9.1% | 0.00% | -50.0% |
| Q3 2020 | $920,000 | +312.6% | 21,216 | +404.3% | 0.00% | +100.0% |
| Q2 2020 | $223,000 | – | 4,207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |